•
Sep 30, 2024

Omega Therapeutics Q3 2024 Earnings Report

Total Revenue
$2.61M
Previous year: $831K
+214.3%
EPS
-$0.3
Previous year: -$0.4
-25.0%
Gross Profit
-$487K
Previous year: -$1.03M
-52.9%
Cash and Equivalents
$30.7M
Previous year: $81.8M
-62.4%
Free Cash Flow
-$14M
Previous year: -$23.8M
-40.9%
Total Assets
$153M
Previous year: $218M
-29.9%

Omega Therapeutics

Omega Therapeutics